AUTIFONY THERAPEUTICS LIMITED - STEVENAGE
Company Profile | Company Filings |
Overview
AUTIFONY THERAPEUTICS LIMITED is a Private Limited Company from STEVENAGE ENGLAND and has the status: Active.
AUTIFONY THERAPEUTICS LIMITED was incorporated 13 years ago on 25/02/2011 and has the registered number: 07543962. The accounts status is GROUP and accounts are next due on 30/06/2024.
AUTIFONY THERAPEUTICS LIMITED was incorporated 13 years ago on 25/02/2011 and has the registered number: 07543962. The accounts status is GROUP and accounts are next due on 30/06/2024.
AUTIFONY THERAPEUTICS LIMITED - STEVENAGE
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
30 / 9 | 30/09/2022 | 30/06/2024 |
Registered Office
STEVENAGE BIOSCIENCE CATALYST
STEVENAGE
HERTFORDSHIRE
SG1 2FX
ENGLAND
This Company Originates in : United Kingdom
Previous trading names include:
NEWINCCO 1091 LIMITED (until 01/06/2011)
NEWINCCO 1091 LIMITED (until 01/06/2011)
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
25/02/2023 | 10/03/2024 |
Map
ENGLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
IP2IPO SERVICES LIMITED | Corporate Director | 2018-03-12 | CURRENT | ||
RANA AL-HALLAQ | Jun 1975 | American | Director | 2019-04-15 | CURRENT |
MR JOHN BERRIMAN | Aug 1948 | British | Director | 2011-05-23 | CURRENT |
CHARLES LARGE | Jun 1967 | British | Director | 2011-05-23 | CURRENT |
MS CATHERINE ELIZABETH BINGHAM | Oct 1965 | British | Director | 2011-08-19 | CURRENT |
OLSWANG DIRECTORS 1 LIMITED | Corporate Director | 2011-02-25 UNTIL 2011-05-23 | RESIGNED | ||
OLSWANG COSEC LIMITED | Corporate Secretary | 2011-02-25 UNTIL 2011-05-23 | RESIGNED | ||
DR BOBBY G. SONI | Nov 1971 | American | Director | 2017-12-15 UNTIL 2018-03-12 | RESIGNED |
MR CHRISTOPHER ALAN MACKIE | Feb 1960 | British | Director | 2011-02-25 UNTIL 2011-05-23 | RESIGNED |
DR ATUL PANDE | Jul 1954 | American | Director | 2014-04-01 UNTIL 2024-01-31 | RESIGNED |
DR ELAINE JONES | Jan 1955 | American | Director | 2013-02-14 UNTIL 2019-04-15 | RESIGNED |
MAINA BHAMAN | Feb 1972 | British | Director | 2011-08-19 UNTIL 2017-12-15 | RESIGNED |
MR ALLAN BAXTER | Feb 1950 | British | Director | 2011-08-19 UNTIL 2015-01-27 | RESIGNED |
GIUSEPPE ALVARO | Sep 1964 | Italian | Director | 2011-05-23 UNTIL 2011-08-19 | RESIGNED |
OLSWANG DIRECTORS 2 LIMITED | Corporate Director | 2011-02-25 UNTIL 2011-05-23 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Pfizer Inc | 2021-11-01 - 2023-01-12 | New York 10017 | Ownership of shares 25 to 50 percent | |
Svls Life Sciences Fund V Lp | 2016-04-06 - 2021-11-01 | Boston Mass | Ownership of shares 25 to 50 percent | |
Touchstone Innovations Businesses Llp | 2016-04-06 | London |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |